Connect Biopharma
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $2,937 | $169 | $16 | $16 |
Gross Profit | 2,937 | 16 | ||
EBITDA | -36,886 | -14,901 | ||
EBIT | -37,211 | -15,082 | ||
Net Income | -36,682 | -19,398 | -15,109 | -17,200 |
Net Change In Cash | 2,937 | 169 | 16 | 16 |
Free Cash Flow | -20,661 | -16,005 | -11,266 | -17,440 |
Cash | 27,015 | 46,034 | 38,345 | 37,845 |
Basic Shares | 62,884 | 62,711 | 55,660 | 55,786 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $64 | $26,033 | $0 | $0 |
Gross Profit | 64 | 26,033 | -988 | -1,030 |
EBITDA | -54,579 | -14,745 | -61,266 | -116,741 |
EBIT | -55,283 | -15,405 | -61,986 | -117,772 |
Net Income | -55,480 | -15,628 | -62,106 | -118,091 |
Net Change In Cash | 64 | 26,033 | 0 | 0 |
Free Cash Flow | -51,640 | -24,362 | -48,224 | -103,551 |
Cash | 38,345 | 78,232 | 105,663 | 79,010 |
Basic Shares | 55,660 | 55,213 | 55,067 | 55,044 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.27 |
2026-03-31 | -$0.26 |
2025-12-31 | -$0.27 |
2025-09-30 | -$0.31 |